Q3 2025 Management View CEO Geoff Martha highlighted mid-single-digit revenue growth for the ninth consecutive quarter, driven by strong performances in cardiac ablation solutions, leadless pacing, ...

The headline numbers for Medtronic (MDT) give insight into how the company performed in the quarter ended January 2025, but it may be worthwhile to compare some of its key metrics to Wall Street ...

Medtronic plc MDT reported adjusted earnings per share (EPS) of $1.39 for the third quarter fiscal of 2025, up 6.9% from the ...

Investment analysts at Leerink Partnrs lowered their Q1 2025 earnings per share estimates for shares of Edwards Lifesciences ...

Edwards Lifesciences beat Q4 estimates with $1.39B in sales, driven by growth in TMTT, TAVR, and Surgical. The company ...

Stroke experts from UCSF Health presented new research and clinical findings at the annual the American Stroke Association’s International Stroke Conference (ISC25), the world’s premier meeting ...

STORA ENSO OYJ FINANCIAL STATEMENT RELEASE 11 February 2025 at 8:30 EET HELSINKI, Feb. 11, 2025 /PRNewswire/ -- Q4/2024 (year-on-year) Sales increased by 7% to EUR 2,322 (2,174) ...

The profit improvement programme, initiated in Q1/2024 with a target of EUR 120 million in annual gross fixed cost savings, progressed well, with the full impact realised from the start of 2025.

Cantor Fitzgerald lowered their FY2025 earnings per share (EPS) estimates for CVRx in a research report issued on Wednesday, ...

The market has misjudged the potential impact of DeepSeek's AI progress, interpreting it as a headwind for tech companies.

In addition to revenue growth, AstraZeneca's core earnings per share climbed 44% to $2.09. Research and development spending ...